TCIM
TTPH

TIAA CREF Investment Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

TIAA CREF Investment Management’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$130K Sell
4,868
-74
-1% -$1.88K ﹤0.01% 2934
2018
Q4 		$112K Hold
4,942
– – ﹤0.01% 2949
2018
Q3 		$273K Sell
4,942
-2,450
-33% -$156K ﹤0.01% 2911
2018
Q2 		$528K Sell
7,392
-754
-9% -$53.2K ﹤0.01% 2763
2018
Q1 		$500K Buy
8,146
+2,263
+38% +$199K ﹤0.01% 2737
2017
Q4 		$741K Sell
5,883
-238
-4% -$30.5K ﹤0.01% 2606
2017
Q3 		$837K Buy
6,121
+1,125
+23% +$150K ﹤0.01% 2606
2017
Q2 		$712K Sell
4,996
-3,088
-38% -$477K ﹤0.01% 2705
2017
Q1 		$1.49M Buy
8,084
+1,725
+27% +$193K ﹤0.01% 2311
2016
Q4 		$513K Sell
6,359
-3,680
-37% -$291K ﹤0.01% 2842
2016
Q3 		$769 Sell
10,039
-1,499
-13% -$120K ﹤0.01% 2665
2016
Q2 		$992K Buy
11,538
+2,481
+27% +$227K ﹤0.01% 2510
2016
Q1 		$839K Hold
9,057
– – ﹤0.01% 2577
2015
Q4 		$1.82M Sell
9,057
-53
-0.6% -$10.6K ﹤0.01% 2217
2015
Q3 		$1.36M Buy
9,110
+1,253
+16% +$920K ﹤0.01% 2382
2015
Q2 		$7.45M Buy
7,857
+2,600
+49% +$2.13M 0.01% 1368
2015
Q1 		$3.85M Buy
5,257
+416
+9% +$312K ﹤0.01% 1810
2014
Q4 		$3.85M Buy
4,841
+862
+22% +$464K ﹤0.01% 1817
2014
Q3 		$1.59M Sell
3,979
-197
-5% -$52.8K ﹤0.01% 2375
2014
Q2 		$1.13M Buy
4,176
+1,900
+83% +$408K ﹤0.01% 2650
2014
Q1 		$496K Hold
2,276
– – ﹤0.01% 2938
2013
Q4 		$615K Hold
2,276
– – ﹤0.01% 2902
2013
Q3 		$518K Buy
2,276
+52
+2% +$9.09K ﹤0.01% 2924
2013
Q2 		$313K Buy
+2,224
New +$352K ﹤0.01% 3021

Other funds holding TTPH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TIAA CREF Investment Management's TTPH Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Tetraphase Pharmaceuticals, Inc. (TTPH) stake by 1.5% in Q1 2019, selling an estimated $1.88K and leaving 4,868 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #2934.

TIAA CREF Investment Management first reported a position in TTPH in Q2 2013 and has held it in 24 quarters since. The position peaked at $7.45M in Q2 2015. 78 funds tracked by Wall St. Rank hold TTPH as of Q1 2019.

  • TIAA CREF Investment Management held 4,868 shares of Tetraphase Pharmaceuticals, Inc. worth $130K as of Q1 2019.
  • TIAA CREF Investment Management sold 74 Tetraphase Pharmaceuticals, Inc. shares in Q1 2019, an estimated $1.88K.
  • Tetraphase Pharmaceuticals, Inc. made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2934 holding.
  • TIAA CREF Investment Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's Tetraphase Pharmaceuticals, Inc. position peaked at $7.45M in Q2 2015.
  • 78 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.